Clinical Trial Update: Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy plus interferon alfa followed by filgrastim in gastrointestinal tract cancers, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrahepatic Bile Duct Cancer
• Gastric Cancer
• Gastrointestinal Carcinoid Tumor
• Liver Cancer
• Pancreatic Cancer
• Small Intestine Cancer

Drugs mentioned

• Filgrastim (filgrastim)
• Interferon Alfa (interferon alfa)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Extrahepatic Bile Duct Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED